Moderate to Severe Chronic Pain May Signal Early Death
The severity of long-term chronic pain that impedes daily life seems to be associated with higher mortality, researchers report.
Sjogren’s Still an Orphan Disease?
Sjogren’s fails a clinical trial with rituximab and a cost analysis. Even with a significant discount, it’s still not cost effective.
Adalimumab Biosimilar Performs Well in RA Trial
The biosimilar adalimumab-atto is equivalent to its reference product — which it slightly outperformed in this trial.
Chondroitin Sulfate as Good as Celecoxib for Knee OA
Study comparing pharmaceutical-grade chondroitin sulfate to celecoxib for knee osteoarthritis shows similar rates of pain relief.
Gout is Poorly Understood, Survey Shows
Most patients feel they can control gout symptoms with modifications to diet and alcohol consumption, shows a survey by CreakyJoints. In this slideshow, we summarize the survey results.
Say what? When Miscommunication Means Life or Death
The nuances of word choice in a doctor’s office may hold greater meaning than you think.
Biologics as First-Line Treatment in Early RA Proves Beneficial
This study is among the first to show that aggressive treatment of early rheumatoid arthritis with biologic DMARDs benefits high-risk patients.
By clicking Accept, you agree to become a member of the UBM Medica Community.